EGF and chronic obstructive pulmonary disease: For example, LHN/C coupled to epidermal growth factor (LHN/C-EGF) was shown to inhibit the release of mucin from pulmonary epithelial A549 cells, demonstrating the potential of such molecules for the treatment of disorders such as asthma and chronic obstructive pulmonary disease (COPD) [99].